Skip to main content
. Author manuscript; available in PMC: 2015 Apr 15.
Published in final edited form as: J Pharm Biomed Anal. 2014 Jan 9;92:63–68. doi: 10.1016/j.jpba.2014.01.001

Table 1.

Calibration Linearity in Plasma (A) or Plasma Pre-Stabilized with 0.1% HCl (B)

A
Nominal (ng/mL) GM (ng/mL) SD (ng/mL) DEV (%) CV (%) n
1 1.00 0.06 −0.09 5.97 8
5 4.88 0.23 −2.40 4.71 8
10 10.18 0.40 1.76 3.96 8
50 50.57 1.99 1.14 3.94 8
100 102.90 3.69 2.90 3.58 8
250 249.33 12.61 −0.27 5.06 8
500 479.79 34.27 −4.04 7.14 8
B
Nominal (ng/mL) GM (ng/mL) SD (ng/mL) DEV (%) CV (%) n
1 0.99 0.07 −0.63 7.28 8
5 5.01 0.64 0.23 12.74 8
10 10.40 1.35 4.04 12.98 8
50 50.27 3.66 0.55 7.27 8
100 99.64 7.42 −0.36 7.45 8
250 249.02 23.76 −0.39 9.54 8
500 481.33 37.44 −3.73 7.78 8

Abbreviations: GM, grand mean; SD, standard deviation; DEV (%), relative deviation from nominal value; CV (%), coefficient of variation; n, number of replicate observations within each validation run, i.e. two samples at each concentration were run on four separate occasions, for a total (n) of eight samples at each concentration.